Doron Nevo - Hadasit Bio External Director

HDST Stock   88.00  6.30  7.17%   

Director

Mr. Doron Nevo was appointed External Director at HBL Hadasit BioHoldings Ltd effective July 29, 2018. His work experience includes the following roles Chief Executive Officer at Kilolambada Technologies and Director at AudioCodes Ltd and Ultra Charge Limited. He holds a BS degree in Electrical Engineering from The Technion Israel Institute of Technology and a MS degree in Telecommunications Management from Polytechnic University in New York. since 2018.
Age 61
Tenure 6 years
Professional MarksMBA
Phone972 2 677 8757
Webhttps://www.hbl.co.il

Hadasit Bio Management Efficiency

The company has return on total asset (ROA) of (0.0296) % which means that it has lost $0.0296 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4387) %, meaning that it generated substantial loss on money invested by shareholders. Hadasit Bio's management efficiency ratios could be used to measure how well Hadasit Bio manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

DIRECTOR Age

Moriah KatrielComputer Direct
55
Yaacov GoldmanMeitav Dash Investments
62
Maayan GaitelbandSkyline Investments
42
Daniel LeventhalSkyline Investments
47
Riki GranotOne Software Technologies
48
Yacov ElinavMeitav Dash Investments
70
Ron EttlingerMagic Software Enterprises
52
Amir TamariSkyline Investments
52
Ilan GrinboimMeitav Dash Investments
52
Yehezkel ZeiraMagic Software Enterprises
72
Rivka GranotOne Software Technologies
50
Ronit NoamMeitav Dash Investments
46
Jonathan AssiaMeitav Dash Investments
34
Moshe VidmanAlrov Properties Lodgings
70
Ronnie BarOnAlrov Properties Lodgings
68
Eitan RaffAlrov Properties Lodgings
76
Shmuel HauserAlrov Properties Lodgings
62
Ronen HarelOne Software Technologies
54
Neil LabatteSkyline Investments
56
Eli NivAlrov Properties Lodgings
60
Lana ShermanSkyline Investments
47
Hadasit Bio-Holdings, Ltd operates in the biotechnology industry in Israel. The company was founded in 2005 and is based in Jerusalem, Israel. HBL HADASIT is traded on Tel Aviv Stock Exchange in Israel. Hadasit Bio (HDST) is traded on Tel Aviv Stock Exchange in Israel and employs 2 people.

Management Performance

Hadasit Bio Leadership Team

Elected by the shareholders, the Hadasit Bio's board of directors comprises two types of representatives: Hadasit Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hadasit. The board's role is to monitor Hadasit Bio's management team and ensure that shareholders' interests are well served. Hadasit Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hadasit Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Yaakov Naparstek, Director
Yigal Erlich, Director
Oren Levy, Sr Director
Rob Fink, IR Contact Officer
Merav Kaye, Director
Michal Sapir, External Director
Baruch Halpert, Chairman of the Board
Alejandro Igelman, VP Fin
Doron Cohen, Internal Auditor
Michel Habib, CEO
Asaf Reisfeld, Director
Yoram Azulay, Vice President - Finance
Doron Nevo, External Director
Ophir Shahaf, CEO
Yaron Kulas, External Director
Ehud Kokia, Director
Einat Zisman, Director
Moise Habib, CEO
Tamar Raz, Director
Elka Nir, External Director
Erez Meltzer, Director
Yoram Azulai, VP CFO

Hadasit Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hadasit Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hadasit Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hadasit Bio's short interest history, or implied volatility extrapolated from Hadasit Bio options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hadasit Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for Hadasit Stock analysis

When running Hadasit Bio's price analysis, check to measure Hadasit Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hadasit Bio is operating at the current time. Most of Hadasit Bio's value examination focuses on studying past and present price action to predict the probability of Hadasit Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hadasit Bio's price. Additionally, you may evaluate how the addition of Hadasit Bio to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Transaction History
View history of all your transactions and understand their impact on performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Please note, there is a significant difference between Hadasit Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hadasit Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hadasit Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.